1-3 of 3
Martin Hjorth, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dexamethasone and Cyclophosphamide: More Convenient and as Effective as VAD before High-Dose Melphalan and Autologous Transplantation in Newly Diagnosed Multiple Myeloma. Results of a Randomized NMSG Trial.

Ulf-Henrik Mellqvist, MD, PhD, Stig Lenhoff, MD, PhD, Martin Hjorth, MD, PhD, Erik Holmberg, PhD, Gunnar Juliusson, MD, PhD, Jon Magnus Tangen, MD, PhD, Jan Westin, MD, PhD, Hans Johnsen, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 793.
https://doi.org/10.1182/blood.V108.11.793.793
Published: 2006
Journal Articles

Impact of Age on Survival after Intensive Therapy in Newly Diagnosed Multiple Myeloma. The Nordic Myeloma Study Group (NMSG).

Stig Lenhoff, MD, Martin Hjorth, MD, Peter Gimsing, MD, Jon Magnus Tangen, MD, Jan Westin, MD
Journal: Blood
Blood (2004) 104 (11): 924.
https://doi.org/10.1182/blood.V104.11.924.924
Published: 2004
Journal Articles

Intensive Therapy in Multiple Myeloma. Long-Term Follow-Up with Focus on Relapse after Transplantation. The Nordic Myeloma Study Group (NMSG).

Stig Lenhoff, MD, Martin Hjorth, MD, Johan Lanng Nielsen, MD, Ingemar Turesson, MD, Finn Wislöff, MD, Jan Westin, MD
Journal: Blood
Blood (2004) 104 (11): 938.
https://doi.org/10.1182/blood.V104.11.938.938
Published: 2004